Daye

📍 Southwark, London, United Kingdom🗓 Founded 2017👥 107 employees💰 Last funded Sep 2025
Daye is a female-founded gynae health start-up on a mission to close the gender health gap for good. We started out with the invention of the world’s first pain-relieving tampon, designed to support the 90% of women who experience menstrual cramps. After helping over 75,000 women & AFAB individuals kick period pain to the curb, we launched our second generation tampon to facilitate the at-home detection of vaginal infections, STIs and HPV. Next, we want to develop solutions for under-served gynae health conditions like endometriosis, PCOS and menopause. Within the next five years, we will build an ecosystem where every woman can understand, monitor, and improve her health from her smartphone.
6
Total investors
2
Early stage
2
Mid stage
2
Late stage
2017
Founded
Investor geography3 countries
United Kingdom
4
Singapore
1
United States
1
Investor activity2019–2025 · investors recorded per year
201922022220252
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Daye?
Daye has 6 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage and 2 late-stage investors.
When did Daye last raise funding?
The most recent investment in Daye recorded on gritt.io was in September 2025.
When was Daye founded?
Daye was founded in 2017.
What industry is Daye in?
Daye operates in Public Health. Find similar Public Health investors on gritt.io.
Where is Daye based?
Daye is headquartered in Southwark, London, United Kingdom.